Editorial: The impact of microbiota and cytokines on inflammatory bowel disease

Curr Pharm Des. 2009;15(18):2049-50. doi: 10.2174/138161209788489131.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Animals
  • Curcumin / therapeutic use
  • Cytokines / antagonists & inhibitors
  • Cytokines / metabolism*
  • Humans
  • Inflammatory Bowel Diseases / etiology
  • Inflammatory Bowel Diseases / metabolism*
  • Inflammatory Bowel Diseases / microbiology*
  • Inflammatory Bowel Diseases / therapy
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / metabolism
  • Intestinal Mucosa / metabolism
  • Intestines / microbiology
  • Leukapheresis / instrumentation
  • Leukapheresis / methods
  • Macrophage Migration-Inhibitory Factors / antagonists & inhibitors
  • Macrophage Migration-Inhibitory Factors / metabolism

Substances

  • Cytokines
  • Interleukin-6
  • Macrophage Migration-Inhibitory Factors
  • Curcumin